DraftKings Poised for Revenue Expansion as Prediction Markets Offer Growth Avenue

BenzingaBenzinga
|||1 min read
Key Takeaway

BofA analyst bullish on DraftKings, projecting 2028 revenue of $8.5-9.1B from core business and emerging prediction markets, though near-term EBITDA will decline due to investments.

DraftKings Poised for Revenue Expansion as Prediction Markets Offer Growth Avenue

Bank of America Securities analyst Shaun C. Kelley outlined a bullish case for DraftKings at the company's investor day, projecting meaningful upside to the sportsbook operator's fiscal 2028 guidance. Kelley expects DraftKings to raise its FY28 revenue forecast to a range of $8.5 billion to $9.1 billion, up from the previously issued $7.1 billion outlook, signaling confidence in the company's core business expansion and new revenue streams.

The analyst's forecast incorporates a significant strategic pivot toward prediction markets, which he projects could represent a $600 billion total addressable market by 2028. Under this scenario, Kelley estimates DraftKings could capture 10-20% of that market, positioning the company to capitalize on an emerging growth category. However, this expansion strategy comes with near-term financial tradeoffs, as Kelley's model assumes EBITDA guidance will be revised downward to $1.5 billion to $1.7 billion due to investments required to build out the prediction market platform.

The analysis reflects a common pattern in growth-stage technology businesses where profitability is subordinated to market share gains in nascent categories. Investors will be watching for management's official guidance updates and capital allocation priorities, particularly regarding how aggressively the company will pursue prediction market penetration relative to near-term earnings.

Source: Benzinga

Back to newsPublished Feb 23

Related Coverage

The Motley Fool

Novo Nordisk's Wegovy Dominates Early Oral GLP-1 Race, But Lilly's Foundayo Shows Promise

Novo Nordisk's Wegovy captures 65% of new oral GLP-1 prescriptions with 1.3M scripts written, while Eli Lilly's Foundayo treats 20K+ patients since April approval.

LLYNVO
The Motley Fool

Plug Power Surges 65% YTD on Turnaround Hopes, But Losses Loom Large

Plug Power shares surge 65% YTD on new CEO's turnaround strategy and 275-MW electrolyzer contract, but $1.69B annual losses raise profitability questions.

PLUGBEFCEL
The Motley Fool

Robinhood's Prediction Markets Bet Could Outpace Crypto Growth

Robinhood enters prediction markets with 27.4M customers, positioning itself against competitors Kalshi and Polymarket to diversify beyond volatile crypto revenues.

HOOD
The Motley Fool

P&G and Colgate Lead Staples Revival: Two Defensive Giants Built for Decades of Returns

Procter & Gamble and Colgate-Palmolive emerge as premier long-term consumer staples plays, leveraging unmatched brand moats and emerging market dominance for sustained growth.

PGCL
The Motley Fool

Arm's Audacious CPU Gambit: $25B Revenue Target and Market Leadership Bid by 2030

Arm predicts CPU market leadership by 2030, with $15B CPU revenue and $25B total revenue by fiscal 2031, but supply constraints currently limit order fulfillment despite $2B in AGI CPU demand.

AMDMETATSM
Benzinga

Alphabet Surges 27% YTD While Investors Split on 2026 Market Leader

Alphabet gains 27% in 2026 as retail investors predict it will surpass Nvidia as most valuable company by year-end, though prediction markets favor Nvidia at 59% odds.

NVDAAMZNGOOG